BioCentury
ARTICLE | Company News

Jingfang, Tongjitang deal

April 13, 2009 7:00 AM UTC

Tongjitang will acquire Jingfang for RMB60 million ($8.8 million) in cash. Jingfang's portfolio of marketed drugs includes Fengshi Gutong Capsules to treat pain associated with rheumatoid arthritis an...